Little is known about the correlation between triggering factors, clinical characteristics, diagnosis, and prognosis of patients with type 2 myocardial infarction (T2MI).
and/or fall in cardiac troponin (cTn) values with at least one value above the 99th percentile upper reference limit (URL); (b) clinical presentation of acute myocardial ischemia; and (c) evidence of an imbalance between myocardial oxygen supply and demand. 3 T2MI may be multifactorial and caused by various conditions, such as anemia, arrhythmia, sepsis, infection, heart failure, respiratory failure, coronary artery spasm, hypertension, hypotension, aortic dissection, severe aortic valve disease, hypertrophic cardiomyopathy, or postoperative factors, but no specific criteria for the diagnosis of T2MI have been established. 4 The lack of objective criteria for T2MI creates a diagnostic uncertainty, which has led to the inconsistent adoption of the classification in clinical practice. Thus far, the classification of T2MI is contentious because of the underlying pathological mechanisms and is based on expert consensus rather than evidence from prospective randomized controlled clinical trials. Patients diagnosed with T2MI are heterogeneous and have myocardial ischemia secondary to a variety of acute medical or surgical conditions. Notably, little is still known about the correlation between triggering factors, clinical characteristics, diagnosis, and prognosis of patients with T2MI. Based on the current criteria, a diagnosis of T2MI could be applied to patients without atherosclerotic plaque disruption. 5 Although patients with T2MI have higher rates of all-cause death compared with those with type 1 myocardial infarction (T1MI), few studies report that the causes of T2MI are associated with a higher mortality rate. In addition, distinguishing different etiologies is essential for clinical management in patients with T2MI, mainly because a large spectrum of underlying causes for T2MI leads to an array of different treatment strategies. [6] [7] [8] [9] Hence, the aim of this review is to assess the triggers of T2MI and to summarize the clinical features of patients with T2MI described in the literature.
| METHODS
There is currently no consensus on the correct tool or measurement parameters to define T2MI, with different troponin I and T value ranges identifying T2MI currently in use. Moreover, there is no universal consensus on the cTn cut-off points that clearly distinguish T2MI from MI. We therefore elected to include papers that had used any of the most commonly accepted metrics, according to a rise and/or fall in cTn values with at least one value above the 99th percentile URL. 3 We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines for this systematic review. 10 The objective of this review was to identify all articles published in PubMed, Embase, and Medline databases between January 2012 and August 2018, which assessed the triggers of T2MI. Multiple variations of the following terms were utilized: cause, contributing factor, trigger, alternate factor, instigating factor, type 2 myocardial infarction, type II myocardial infarction, and myocardial infarction type 2. Additional references were identified from conference proceedings and/or citations in relevant review articles and assessed to find all available papers.
The inclusion criteria were as follows: (a) the definition, different causes, and baseline features of T2MI were mentioned; (b) an available clinical database was used; and (c) the study design met the requirement of high or acceptable quality assessment; especially, the single-and multiple-trigger T2MI should be both included in selected studies. The exclusion criteria were as follows: (a) duplicate reporting;
(b) lack of outcome data; and (c) non-English publication.
Two investigators (G.Q.W. and N.Z.) independently evaluated the titles and abstracts of the articles retrieved using the search strategy.
Abstracts that did not meet the inclusion criteria or met exclusion criteria were discarded. We selected the remaining studies for fulltext evaluation and data extraction. Any disagreements regarding the inclusion or exclusion of a study were solved by consensus, and, if doubt persisted, a third reviewer (J.P.L.) evaluated the reference.
Therefore, we extracted data on the different causes of T2MI, which contained arrhythmia, anemia, respiratory failure, hypotension, infection and sepsis, heart failure, hypertension, postoperative factors, and other factors. Additionally, the data of multi-trigger T2MI was extracted from selected studies.
| RESULTS
Our literature search identified 7386 articles corresponding to the key terms; 7306 were excluded because they were not relevant based on the title and abstract. The full text of 80 articles was evaluated and 14 articles were ultimately included in this review. After screening the reference list of all included articles, no articles were added to this review. A detailed description of the selection process is presented in To evaluate the quality of included studies, we applied the improved Newcastle-Ottawa Quality Assessment Scale (NOS) for nonrandomized studies. 11 All prospective or retrospective cohort studies received a rating of high (NOS ≥7) or acceptable quality (NOS ≥6) in this systematic review, respectively.
The baseline clinical characteristics and treatment of patients with T2MI are summarized in Table 1 . 4, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] The mean age of patients with T2MI was over 60 years; most studies revealed that the percentage of male patients ranged from 52.8% to 98.6% in patients with T2MI, found percentages of female patients of 60.3%, 59%, and 51.9%, respectively. 17, 18, 24 The ratio of patients with T2MI presenting with non-ST segment elevation myocardial infarction (NSTEMI) ranged from 70.1% to 97.5% (mean value: 87.1%); all studies found that patients with T2MI often had previous relevant medical history, but EI-Haddad et al. did not describe medical history findings. 12 Only seven studies described the multiple medications used by patients with T2MI after discharge, which mainly included aspirin, P2Y12 inhibitors, beta blockers, angiotensin-converting enzyme inhibitor (ACEI), angiotensin II receptor blocker (ARB), and statins. Detailed medication regimens are also described. Eleven studies showed 5% to 60.5% (mean value: 26.1%) of patients with T2MI were diagnosed by coronary angiography, and 10 studies showed that 0% to 51.1% (mean value: 11.1%) of patients with T2MI received percutaneous coronary intervention (PCI).
The triggers for T2MI are shown in Table 2 Figure 2 shows the comparison between the single-and multipletrigger T2MI in six selected studies and shows that the proportion of single-trigger T2MI was higher than that of multiple-trigger T2MI, while Figure 3 shows that 2-trigger T2MI constituted the majority of multiple-trigger cases. 15, 16 
| DISCUSSION
A key finding of this review is that the clinical characteristics of patients with T2MI, which were similar to those of found by Gupta et al. 25 Patients with T2MI were older, more often men, more frequently presented with NSTEMI, and had a higher prevalence of cardiovascular risk factors or comorbidities, such as hypertension, smoking, dyslipidemia, diabetes, obesity, heart failure, impaired renal function, anemia, coronary artery disease, atrial fibrillation, cancer, peripheral artery disease, and chronic obstructive pulmonary disease.
In this review, most selected studies revealed that the number of men with T2MI was higher than that of women, while a reduced number T A B L E 1 (Continued) of studies found the opposite. 17, 18, 24 For example, Gupta et al.
described T2MI was more common in females compared with T1MI. 25 Among the clinical characteristics of T2MI, we concluded that cardiovascular risk factors or comorbidities might be the most important causes of T2MI and affect the prognosis in these patients. The poor short-and long-term prognosis is not entirely surprising since T2MI typically occurs among older patients with greater comorbidities and is identified in the context of hemodynamic instability. 26 24 Few studies confirm that T2MI has worse outcomes independent of severe concomitant diseases. On the other hand, patients with T2MI were less likely to undergo coronary angiography (CAG) or PCI or to receive secondary preventive treatment than patients with T1MI. The impact of anti-thrombotic and/or antiplatelet therapy, as well as the role of reperfusion in patients with T2MI due to mild atherosclerotic coronary stenosis might be beneficial or effective, but in patients without plaque rupture this benefit is uncertain and there might even be a detrimental effect or contraindication to treatment in many cases. 19, 29 Otherwise, patients with T2MI often receive specific treatments for concomitant diseases, such as anticoagulants for atrial fibrillation or diuretics for heart failure. Regardless of the definition, we agree that the optimal medical therapy should be based on the cause of T2MI.
This review systematically evaluated T2MI triggers and listed the leading cause and other common causes, especially in single-trigger cases; our findings also shed light on the underlying etiologies, which may help improve the decision regarding treatment options. In the TRACER trial, the most frequent potential provoking factor for T2MI was tachyarrhythmia (38.2%), which is consistent with our findings. 30 A meta-analysis also demonstrated that the most common associated arrhythmia was tachyarrhythmia, especially atrial fibrillation, in patients with T2MI. 25 Most patients with T2MI died from noncardiovascular causes during long-term follow-up. However, few studies described the association between cardiovascular trigger and prognosis in patients with T2MI, which is crucial for clinicians. There are several limitations to this systematic review. First, it is based on a relatively small number of selected patients. T2MI cases are not representative of the local population they were been derived from, and the study population is heterogeneous. The study period is narrow and might not be able to represent the whole spectrum of patients with T2MI adequately. In addition, selection bias may be present due to the heterogeneity of included patients due to the subjectivity of the diagnostic criteria for T2MI and to the different diagnostic methods used. 33 Second, the objectives of individual studies are variable. This has potential consequences on the procedures used and on the reliability of how underlying conditions and their distribution among T2MI cases were established. Third, this review only includes retrospective and prospective cohort studies, but not prospective randomized controlled studies. Several selected studies have incomplete documentation for the key factors in this investigation. All individual studies lack information on how the underlying causes were established. Despite a rigorous statistical analysis, residual confounding and selection bias are likely to be present.
| CONCLUSION
The leading trigger of T2MI was arrhythmia, especially tachyarrhythmia, and single-trigger cases represented the majority of cases. Among multiple-trigger cases of T2MI, two-trigger cases are the most common. T2MI often occurs in older patients with cardiovascular risk factors or comorbidities. As for the triggering factors, non-cardiovascular causes are closely related to the diagnosis and prognosis of T2MI. Furthermore, the optimal medical therapy should be decided based on the trigger of T2MI. Although recent data are promising, more prospective randomized controlled studies are necessary to verify the impact of different triggers on the diagnosis, treatment, and prognosis of T2MI.
